Metraipolis › archive › dc_62d106958370

Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles — Europe PMC PMID:41221047

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41221047
DOI: 10.3389/fphar.2025.1620922
License (as archived): solo-consultazione
Archived: 2026-11-09T01:16:40.540Z
SHA-256 of the archived text: 8dd5da2345d47e67e877c9e164afac4388ea48d2f7eeafda4d169a78360bf0b8
Stable URL of this page: https://metraipolis.com/documento/dc_62d106958370

How to cite

Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles — Europe PMC PMID:41221047 — Europe PMC (en), https://europepmc.org/article/MED/41221047 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_62d106958370 (Metraipolis archive dc_62d106958370, sha256 8dd5da2345d47e67e877c9e164afac4388ea48d2f7eeafda4d169a78360bf0b8)

BibTeX

@misc{dc62d106958370,
  title = {Stereotactic body radiotherapy (SBRT) in oligometastatic ovarian cancer (OMOC): a systematic review and meta-analysis of clinical outcomes and toxicity profiles — Europe PMC PMID:41221047},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41221047},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_62d106958370; sha256 8dd5da2345d47e67e877c9e164afac4388ea48d2f7eeafda4d169a78360bf0b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41221047. Agents can read the archived copy with the MCP tool read_document.